特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
957353

ラベルフリーアレイシステムの世界市場

Label-free Array Systems

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 235 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

ラベルフリーアレイシステムの世界市場
出版日: 2020年09月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 235 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のラベルフリーアレイシステムの市場規模は、分析期間(2020年~2027年)に5.3%のCAGRで成長する見通しで、2020年の13億米ドルから2027年には18億米ドルに達すると予測されています。当レポートで分析されているセグメントの1つである表面プラズモン共鳴(SPR)は、分析期間中に5.5%の年率で成長し、13億米ドルに達すると予測されています。

当レポートは、世界のラベルフリーアレイシステム市場について調査しており、市場シェア、動向や見通し、成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Agilent Technologies, Inc.
  • Attana AB
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • ForteBio
  • GWC Technologies
  • Molecular Devices LLC
  • PerkinElmer, Inc.
  • Riot Blockchain, Inc.

目次

I. イントロダクション、調査手法、調査範囲

II. エグゼクティブサマリー

  • 市場概要
    • 競合の市場シェア
    • 競合の市場シェアシナリオ
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と成長要因
  • 世界市場の見通し

III. 市場分析

  • 地域別市場分析
  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • 企業プロファイル:43社
目次
Product Code: MCP16527

Global Label-free Array Systems Market to Reach $1.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Label-free Array Systems estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Surface Plasmon Resonance (SPR), one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bio-layer Interferometry (BLI) segment is readjusted to a revised 4.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $375.2 Million, While China is Forecast to Grow at 5.1% CAGR

The Label-free Array Systems market in the U.S. is estimated at US$375.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$323.5 Million by the year 2027 trailing a CAGR of 5.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Cellular Dielectric Spectroscopy (CDS) Segment to Record 5.2% CAGR

In the global Cellular Dielectric Spectroscopy (CDS) segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$58.5 Million in the year 2020 will reach a projected size of US$84.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$204.3 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 235-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Agilent Technologies, Inc.
  • Attana AB
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • ForteBio
  • GWC Technologies
  • Molecular Devices LLC
  • PerkinElmer, Inc.
  • Riot Blockchain, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Label-free Array Systems Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Label-free Array Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 2: World Historic Review for Label-free Array Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Label-free Array Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Surface Plasmon Resonance (SPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 5: World Historic Review for Surface Plasmon Resonance (SPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Surface Plasmon Resonance (SPR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Bio-layer Interferometry (BLI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 8: World Historic Review for Bio-layer Interferometry (BLI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Bio-layer Interferometry (BLI) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 11: World Historic Review for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Quartz Crystal Microbalance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 14: World Historic Review for Quartz Crystal Microbalance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Quartz Crystal Microbalance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 17: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Antibody Characterization and Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 20: World Historic Review for Antibody Characterization and Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Antibody Characterization and Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Protein Interface Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 23: World Historic Review for Protein Interface Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Protein Interface Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Protein Complex and Cascade Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 26: World Historic Review for Protein Complex and Cascade Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 27: World 15-Year Perspective for Protein Complex and Cascade Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 29: World Historic Review for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 30: World 15-Year Perspective for R&D Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 32: World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 33: World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Agriculture Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 35: World Historic Review for Agriculture Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 36: World 15-Year Perspective for Agriculture Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 37: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 38: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 39: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Label-free Array Systems Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 40: USA Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 41: USA Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 42: USA 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 43: USA Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 44: USA Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 45: USA 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 46: USA Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 47: USA Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 48: USA 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 49: Canada Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 50: Canada Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 51: Canada 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 52: Canada Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 53: Canada Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 54: Canada 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 55: Canada Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 56: Canada Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 57: Canada 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 58: Japan Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 59: Japan Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 60: Japan 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 61: Japan Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 62: Japan Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 63: Japan 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 64: Japan Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 65: Japan Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 66: Japan 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 67: China Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 68: China Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 69: China 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 70: China Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 71: China Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 72: China 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 73: China Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 74: China Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 75: China 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Label-free Array Systems Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 76: Europe Current & Future Analysis for Label-free Array Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027
    • TABLE 77: Europe Historic Review for Label-free Array Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 78: Europe 15-Year Perspective for Label-free Array Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 79: Europe Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 80: Europe Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 81: Europe 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 82: Europe Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 83: Europe Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 84: Europe 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 85: Europe Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 86: Europe Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 87: Europe 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 88: France Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 89: France Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 90: France 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 91: France Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 92: France Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 93: France 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 94: France Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 95: France Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 96: France 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 97: Germany Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 98: Germany Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 99: Germany 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 100: Germany Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 101: Germany Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 102: Germany 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 103: Germany Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 104: Germany Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 105: Germany 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 106: Italy Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 107: Italy Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 108: Italy 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 109: Italy Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 110: Italy Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 111: Italy 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 112: Italy Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 113: Italy Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 114: Italy 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 115: UK Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 116: UK Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 117: UK 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 118: UK Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 119: UK Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 120: UK 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 121: UK Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 122: UK Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 123: UK 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 124: Rest of Europe Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 125: Rest of Europe Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 126: Rest of Europe 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 127: Rest of Europe Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 128: Rest of Europe Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 129: Rest of Europe 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 130: Rest of Europe Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 131: Rest of Europe Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 132: Rest of Europe 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 133: Asia-Pacific Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 134: Asia-Pacific Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 135: Asia-Pacific 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 136: Asia-Pacific Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 137: Asia-Pacific Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 138: Asia-Pacific 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 139: Asia-Pacific Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 140: Asia-Pacific Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 141: Asia-Pacific 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 142: Rest of World Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 143: Rest of World Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 144: Rest of World 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027
    • TABLE 145: Rest of World Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 146: Rest of World Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 147: Rest of World 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027
    • TABLE 148: Rest of World Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027
    • TABLE 149: Rest of World Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019
    • TABLE 150: Rest of World 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 43
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.